chr11-64556256-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018484.4(SLC22A11):c.257G>A(p.Arg86His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018484.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A11 | NM_018484.4 | c.257G>A | p.Arg86His | missense_variant | 1/10 | ENST00000301891.9 | NP_060954.1 | |
SLC22A11 | NM_001307985.2 | c.257G>A | p.Arg86His | missense_variant | 1/8 | NP_001294914.1 | ||
SLC22A11 | XM_011545167.2 | c.-39G>A | 5_prime_UTR_variant | 1/9 | XP_011543469.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249632Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135302
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461402Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727034
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.257G>A (p.R86H) alteration is located in exon 1 (coding exon 1) of the SLC22A11 gene. This alteration results from a G to A substitution at nucleotide position 257, causing the arginine (R) at amino acid position 86 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at